New anticancer agents: Recent developments in tumor therapy

Riyasat Ali, Zeenat Mirza, Ghulam M.D. Ashraf, Mohammad Amjad Kamal, Shakeel Ahmed Ansari, Ghazi Abdullah Damanhouri, Adel Mohammad Abuzenadah, Adeel Ga Chaudhary, Ishfaq Ahmed Sheikh

Research output: Contribution to journalReview article

95 Scopus citations

Abstract

Increasing recurrence of mammalian tumors and severe side-effects of chemotherapeutic agents reduce the clinical efficacy of a large variety of anticancer agents that are currently being used. Thus, there is always a constant need to develop alternative or synergistic anticancer drugs with minimal side-effects. One important strategy to develop effective anticancer agents is to study into anticancer agents derived from natural sources. Anticancer agents derived from plants and their derivatives have been proven to be effective for cancer prevention and therapeutics. Vinca alkaloid and their derivatives, alone and in combination with therapeutic agents, have been used for a long time for the treatment of various types of cancers. Polyphenols form one of the most important and extensively used classes of plant-derived therapeutics for cancer prevention or chemotherapy. The present review highlights a plethora of studies focused on the antineoplastic properties of plant-derived chemicals, such as Vinca alkaloid, saponins, and flavonoids.

Original languageEnglish (US)
Pages (from-to)2999-3005
Number of pages7
JournalAnticancer Research
Volume32
Issue number7
StatePublished - Jul 1 2012

Keywords

  • Natural products
  • New anticancer agents
  • Plant-derived chemicals
  • Review

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'New anticancer agents: Recent developments in tumor therapy'. Together they form a unique fingerprint.

  • Cite this

    Ali, R., Mirza, Z., Ashraf, G. M. D., Kamal, M. A., Ansari, S. A., Damanhouri, G. A., Abuzenadah, A. M., Chaudhary, A. G., & Sheikh, I. A. (2012). New anticancer agents: Recent developments in tumor therapy. Anticancer Research, 32(7), 2999-3005.